View in browser
logo-1

June 5, 2020

outbreak-global-weekly-banner
The weekly global report provides brief updates on COVID-19 related activity and policy development in AdvaMed’s priority markets. For additional information, please contact Ralph Ives at Rives@AdvaMed.org.

COVID-19 Outbreak: Weekly Global Report for Friday, June 5, 2020

 

AdvaMed recognizes that its members, particularly those with global government affairs responsibilities, are tracking COVID-19 related developments around the world to assess the public health and economic impacts on their businesses. Knowing that companies are consuming information from a variety of sources, AdvaMed's global team would like to provide members with a weekly snapshot of the key statistics, policy developments and advocacy initiatives underway in our priority markets.  If you have any suggestions as we ramp up this work stream, we welcome your feedback.

 

Global

  • Weekly COVID-19 statistics- Global cases topped 6.5 million – a one million increase over the previous week, and deaths reached 387,568 (an increase of over 25,000) in 185 nations.
  • U.S. cases exceeded 1.86 million, with deaths increasing to 107,450 – an increase of 6,450 over the previous week.
  • Staff Contact: Ralph Ives (rives@advamed.org).

China

  • Weekly COVID-19 statistics – China continues to report only a few cases each day and, on some days, no new cases at all. Total cases stand at 84,166 and deaths at about 4,638.
  • Starting Mon. June 8, China will ease flight restrictions on foreign airlines. Foreign airlines will be allowed to conduct one commercial passenger flight per week to the Chinese mainland, with the possibility of increasing to two per week if no passengers test positive for COVID-19. This policy change comes after the U.S. threatened to ban Chinese airlines from operating a once weekly flight to the U.S., should China did not afford reciprocity to U.S. carriers.
  • Overall, manufacturing remains at 80-85% of the level before the outbreak. Consumer spending still remains below pre-pandemic levels, although the government is taking policy steps to boost consumer spending and sentiment.
  • Elective/regular surgeries and other medical services are almost back to normal, except for Beijing.
  • The Phase One trade agreement is proceeding with implementation. However, both governments are ramping up rhetoric over blame for the coronavirus and Hong Kong, which could lead to retaliatory measures. In apparent retaliation against the Trump administration’s condemnation of the Hong Kong security law, China has halted some U.S. farm imports.
  • Staff Contact: Ralph Ives (rives@advamed.org).

India

  • Weekly COVID-19 statistics –106,737 active cases with 6,975 deaths as compared to 86,110 active cases with 4,531 deaths reported last week. 
  • Over the weekend, India announced plans to further loosen the government's lockdown restrictions. Starting June 8, restaurants, hotels, shopping malls, and places of worship located in containment zones will be allowed to re-open in the first stage of a three-phase plan. The government's lockdown measures, which are now scheduled to expire on June 30, have only been extended for the country's containment zone areas.
  • The government relaxed visa and travel restrictions to permit certain categories of Foreign Nationals to come to India.
  • Prime Minister Modi expressed optimism on Tuesday about the country’s ability to bounce back from the lockdown and get the economy back on track. This comes a week after Moody downgraded India’s credit rating.
  • As lockdown restrictions are eased, the country is beginning to experience spikes in rural areas as migrant workers return home. This raises new concerns about the ability of rual communities with weak health infrastructure to handle an influx of cases.
  • India approved Gilead Sciences's antiviral drug Remdesivir for emergency use. Gilead recently concluded phase 3 trials and noted that patients who received a 5-day dose of Remdesivir fared better than patients who received the drug over a 10-day period.
  • Staff Contact: Abby Pratt (apratt@advamed.org).

Japan

  • Weekly COVID-19 statistics – 17,790 reported cases and 923 reported deaths compared to 17,471 reported cases and 895 reported deaths the previous week.
  • Japanese prefectures and cities have begun slowly resuming regular activity, but clusters centered on hospitals in Tokyo and Kitakyushu last week have raised concerns around the potential for a second wave.
  • Tokyo entered “phase two” of its three-part reopening plan on June 1 reopening movie theaters, gyms, and cram schools. However, the governor issued a “Tokyo alert” about a sudden uptick in cases on June 2 and warned residents against excursions to nightlife hotspots, the center of several recent domestic transmission clusters.  Tokyo may reimpose restrictions on nonessential excursions and business operations if new cases bounce back to higher than an average of 20 per day over one week.
  • The national government is reportedly considering easing restrictions on business travel from Vietnam, Thailand, Australia, and New Zealand as a first step toward opening Japan wider to international visitors.
  • Japan experienced a 40% decline in patient hospital visits in April compared to a year earlier.  This follows guidance from the Ministry of Health to the prefectures requesting them to encourage the postponement of procedures and surgeries that are deemed by physicians, in consultation with their patients, to be non-essential at present.
  • Japan's Ministry of Health announced that it will adopt priority regulatory review procedures for new COVID-related medical devices.
  • Japan will ban foreign companies from purchasing advanced medical device companies that are deemed essential to the national security in the fight against Covid-19. This measure is based on concerns about China but applies to companies from all countries.  The government aims to ensure stable supply of essential devices that are vulnerable to contamination by infection, such as implants and dialyzers.
  • Staff Contact:  Phil Agress (PAgress@AdvaMed.org).

Korea

  • Weekly COVID-19 statistics - South Korea continues its pattern of recovery from COVID-19, but the new cases continue to be above the levels from two weeks ago.  Last week, the daily cases spiked to 79 per day.  This week it is down to 39.  There are 11,629 cases, 857 active with 273 deaths. Current daily death totals are just 1. 
  • Korea continues to exhibit one of the lowest global death rates from COVID at just 2.4%. 
  • Officials in Seoul have rescinded some easing measures, imposing a two week phase of stringent physical distancing, until at least June 14.  Thousands of bars and entertainment venues have been re-closed in and around Seoul.  Overall, the country continues to re-open and over 1.7 million students have returned to classes this week. 
  • The Korean economy contracted by 1.4% in Q1. The Korean government is projecting negative growth, as is the IMF.
  • South Korea has launched a $33 Billion bailout for large companies, starting with airlines and shippers. This is expected to be followed by a second release of funds to aid smaller companies.  South Korea has also set aside 500B Won to provide guaranteed loans auto parts manufacturers. 
  • The South Korea Center for Disease Control (KCDC) has been elevated to agency status. This highlights the importance being given to pandemic prevention and policy. 
  • South Korea maintains its 2-week quarantine for all other incoming international travelers and a requirement for all inbound flights to check passengers' temperatures. Anyone with a temperature over 37.5 degrees Celsius (99.5 Fahrenheit) is denied entry. Korea has still not issued any guidance on an exemption that is supposedly available.  Korea has indicated all US inbound travelers will be tested for symptoms prior to being moved to quarantine.
  • Korea is considering a proposal that would potentially reduce the price of certain cardiac stents. AdvaMed continues to be in touch with members and the medtech association in Korea and is prepared to engage at the appropriate time if necessary.
  • Resources: http://ncov.mohw.go.kr/en/. 
  • Staff Contact: Joseph Gatewood (jgatewood@advamed.org).

ASEAN

  • Weekly COVID-19 statistics – 96,286 reported cases and 2,877reported deaths, compared to 82,706 reported cases and 2,579 reported deaths the previous week.
  • The bulk of infections are in Singapore, Indonesia, and the Philippines.  Indonesia and the Philippines account for 92% of reported deaths in the region.
  • Most key ASEAN countries have put a hold on non-emergency surgery.  At least one major hospital in Vietnam has resumed elective surgeries.  Starting June 2, Singapore will allow certain procedures, including cancer screening, surgical operations for advanced cataracts, flu vaccinations and dental procedures. Malaysia and the Philippines are beginning to plan for the resumption of elective surgery once recovery milestones are met.
  • Indonesia is preparing to implement a “new normal” whereby most non-essential businesses, malls, and places of worship can operate with strict health protocols.
  • Singapore reopened schools and other businesses following the expiration of the county's "circuit breaker" lockdown measures. The government has permitted 75 percent of the economy to reopen but retail establishments, gyms, and bars remain closed.  Virus transmission rates have stabilized in the past few weeks following outbreaks in dormitories housing foreign workers. Infections among the general population remain low.
  • While Malaysia’s COVID-19 transmission rate remains under control, experts fear a virus surge in the coming weeks following travelers breaking quarantine to celebrate the end of Ramadan.
  • Thailand has set July 1 as the date for the lifting of all business and activity lockdowns surrounding the COVID-19 pandemic. This will include lifting the ban on international travel, as well as the end of emergency decree and curfew.
  • Vietnam has been one of the best performers globally in terms of health and economic outcomes, having reported zero deaths and the highest GDP growth expectancy amid the pandemic. Major Vietnamese airlines have resumed all domestic flight services, and the Vietnamese government is discussing resuming international flights with Japan and Korea.
  • Myanmar has gradually eased COVID-19 restrictions after no new local transmissions of the disease were reported for two weeks. 
  • Staff Contact:  Phil Agress (PAgress@AdvaMed.org)

Europe

 

Europe looks much improved from last week.  Total cases are down in France.  France, Spain, Italy, Belgium and the UK are showing fewer new cases per day.  Spain is slightly ahead in the number of cases, but the UK remains the country that has had the most deaths from COVID.  Mortality rates and deaths per day in most EU countries still appear to remain on a downward trend.  Although not in the EU, Russia's reported numbers on COVID are continuing to get dramatically worse each week, and they may end up being the worst in Europe.  (Russia is purportedly at over 432,277 cases, with interestingly just over 5,215 reported deaths).  This remains a concern for EU countries who are looking to reopen borders. 

 

EU Chart for Gloal Weekly
  • New daily cases, which tends to show which countries are increasing in COVID incidence is as follows:  Spain 394; Italy 321; Germany 334; France 352; UK 1,805; Belgium 82. (All of these countries are showing leveling numbers, with most decreasing).  France has had a dramatic drop in the total number of cases.
  • New deaths per day are as follows:  Spain 1; Italy 71; Germany 25; France 81; UK 359; Belgium 17 (All have decreased from last week).
  • The EU’s coronavirus recovery package is now on track to be supported by all member states.  Called Next Generation EU, the package consists of 500 billion Euro in grants and another 250 billion Euro in loans.  Initially suggested by France and Germany, the package contains linkages to innovation, digitalization and green technology development.  The EU Commission will raise the necessary funds on international markets leveraging its AAA rating and then allocate to member states that are hardest hit by COVID.
  • The European Central Bank announced further stimulus measures Thursday to help Europe’s economy and counter the coronavirus impact.  The bank said it will expand its bond buying program by another 600 billion euros ($675 billion). This brings the total pandemic emergency purchase program to 1.35 trillion euros ($1.52 trillion). 
  • Consumer prices are expected to fall significantly in the EU, while spending on coronavirus relief measures will push the deficits of European governments from just 0.6% of GDP in 2019 to around 8.5% this year. The Commission predicts that EU unemployment will increase from 6.7% in 2019 to 9% this year.
  • The UK government has begun a large-scale study of coronavirus immunity, which is intended to track the spread of the virus through the general population.  Persons who test positive for COVID in England will be contacted by one of the country’s 25,000 tracers. 
  • About 30,000 people in the UK had to be retested for coronavirus after the government decision to send swabs to the US for analysis backfired.  Nearly 30,000 out of 67,000 tests sent to the US for processing were ‘voided’ for the manner they had been processed.  The Department of Health this week indicated it had hit its 200,000 test per day target. 
  • The UK continues its struggle to rebuild drug stockpiles that have been devasted by COVID.  Adding to this is the tenor of the UK/EU negotiations and fears of a ‘no-deal’ Brexit.  The government is developing a plan to replenish the stockpiles. 
  • The UK held a ‘virtual vaccine summit” this week with many outside the UK in virtual attendance.  The event raised $8.8 billion for vaccine production and distribution.  They also raised $2 billion for a procurement fund to ensure poorer countries can access the vaccine.    
  • From June 15, face coverings are compulsory on public transport in the UK.  On June 8, London is beginning limited re-opening for some workers.
  • Effective June 8 in the UK, there will be a mandatory 14-day quarantine for incoming international travelers.  Incoming travelers must provide officials with their plans for self-isolation or risk being routed to government provided facilities. There are some exceptions for healthcare and other workers deemed essential. ABHI has confirmed that individuals with specialist skills within the medical device sector are exempt from this rule. The policy will be reviewed and possibly modified during the week of June 28.   
  • The German government has utilized a ‘workshare’ system to subsidize employer payrolls and discourage layoffs.  In exchange employees work fewer hours and agree to spread existing work among the entire staff, while receiving a large percentage of their normal salaries.  This has allowed Germany to spend significantly less during the pandemic than comparable countries and dramatically reduce the productivity decrease that would occur if employees were laid off. 
  • The number of corona patients undergoing intensive medical treatment has decreased significantly in Germany over the past few weeks. As of Tuesday, 689 people suffering from Covid-19 were cared for in intensive care units, about half of them were ventilated. In mid-April, the number of patients had at times been more than 2900.
  • German hospitals are re-opening and there is a large backlog for elective procedures.  Patients are being reassured through public affairs messages of the measures that are in place to ensure safety from COVID.  But there remains hesitancy for patients to undertake elective procedures at pre-Covid levels.
  • Germany has decided to lift the worldwide travel warning for 29 European countries as of June 15 and replace it with ‘travel warnings.’  This does not apply to Norway or Spain, which have travel bans in place that extend beyond June 15.     
  • This week, restaurants, bars and cafes re-opened throughout France for the first time in almost 3 months.  However, in Paris these establishments can only seat customers in outdoor terraces if they have that capacity.  The number of French cafés is decreasing dramatically.  According to industry statistics, two cafés go out of business every day – an alarming rate that is likely to accelerate after months of lockdown and with a deep recession looming.
  • France’s National Assembly has approved a StopCovid tracking app, but not without strong opposition from those who have privacy concerns about this type of application.  There was significant opposition to the approval.  The app is now being used.    
  • France has cancelled its July 14 military parade over Covid concerns. 
  • We have heard one instance of a potential issue with products being blocked by the EU's export restriction on PPE. If you are experiencing difficulties with this restriction, please let us know immediately.
  • The proposed one-year suspension of implementation of the EU's MDR is now final.  The measure extends until May 26, 2021 the date of application of the current regulation but does not extend every target deadline referenced in the law.  It also creates the possibility of EU-wide derogations for specific medical devices.
  • https://ec.europa.eu/commission/presscorner/detail/en/IP_20_718;
  • https://www.medtecheurope.org/news-and-events/press/medtech-europe-welcomes-the-amendment-of-the-medical-devices-regulation-and-urges-similar-action-for-the-ivd-regulation/.
  • AdvaMed's joint programs in Germany and the UK continue to provide COVID-19 updates and support on MDR implementation.
  • Resources: https://www.ecdc.europa.eu/enlll;
  • https://www.europarl.europa.eu/news/en/headlines/priorities/eu-response-to-coronavirus;
  • https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public;
  • https://www.ecdc.europa.eu/en;
  • https://ec.europa.eu/info/live-work-travel-eu/health/coronavirus-response/economy_en;
  • https://www.abhi.org.uk/what-we-do/abhi-covid-19-hub/;
  • https://ec.europa.eu/commission/presscorner/detail/en/IP_20_582;
  • https://www.bundesgesundheitsministerium.de/en/press/2020/coronavirus.html;
  • https://www.medtecheurope.org/covid-19-information-hub;
  • https://www.medtecheurope.org/resource-library/european-industry-trade-and-supply-chain-needs-to-respond-to-covid-19/;
  • https://www.medtecheurope.org/wp-content/uploads/2020/03 European_Union_Emergency_Support_Instrument_for_the_healthcare_sector_-_questions_and_answers.pdf;
  • https://www.medtecheurope.org/resource-library/eu-materials-covid-19/.
  • Staff Contact:  Joe Gatewood (jgatewood@advamed.org)

 Latin America

 

LATAM For Global Weekly

Regional

  • COVID-19 still ramping up in Latin America; cases up 37% over the previous week.

Brazil

  • The majority of the 250+ COVID-19 measures that the Brazilian government has implemented have been deemed positive for the medtech sector response.
  • Concern remains regarding the dozen+ proposed related bills on the economic regulation of medical technology.
  • Economic pressure wins out over health advice

Mexico

  • AdvaMed member and supplier production in the Mexico border states has remained uninterrupted for the past week.

Other Highlights (Source: Prospectiva)

Argentina: National quarantine extended amidst focalized protests against lockdown measures.

Bolivia: Government relaxes quarantine measures as cases continue to rise

Brazil: Political tensions continue as the government tries to deal with the crisis

Chile: As President Piñera calls for national unity, health situation in Santiago remains critical

Colombia: Government extends national quarantine with widened exceptions.

Ecuador: Government suspends use of hydroxychloroquine as treatment for COVID-19.

Mexico: AMLO announces operational budget cuts of 75% and announces national tour to inaugurate infrastructure projects. 

Paraguay: Rescinded contracts continue to prompt turmoil.

Peru: Government announced that it is working on a bill for the reform of public procurement processes.

Uruguay: Bilateral Agreement expected after cases increased on the Brazilian border zone

 

coronavirus-flash-brief-footer
Facebook
LinkedIn
Twitter
YouTube

AdvaMed, 701 Pennsylvania Ave, Suite 800, Washington, DC 20004, 202-783-8700

Unsubscribe Manage preferences